The acquisition of TERT promoter mutation in BRAF or NRAS mutated melanoma probably allows the re-expression of TERT leading to the immortalization process on path to melanoma development, together with other alterations such as inactivation of cyclin-dependent kinase inhibitor 2A (CDKN2A). Here, TERT is linked to melanoma.